ProtAge: Biomarker panel and software to predict your proteomic age
ProtAge accurately predicts proteomic age, offering a powerful tool for preventive and precision medicine.
Applications: Personalised risk prediction, patient stratification, trial recruitment and read outs
| Features | Benefits |
|---|---|
| Measures clinically relevant accelerated ageing, not merely chronological age | Provides actionable diagnostic/prognostic signals, as well as defining proteomic age |
| Validated across three geographically and genetically distinct populations | Credible across populations, making it an assay that can be truly international |
| Broad disease and mortality association from one test | Potential for a single systemic ageing measurement relevant across multiple disease areas, supporting screening and risk stratification |
| Only 20 proteins needed for the compact ProtAge20 clock | Creates a lower-cost, targeted diagnostic panel with simpler workflows and higher throughput |
| Software appropriate for supporting clinical trial readouts | Published examples showing that the software provides value in trials |
Awaiting patent and Available For
- Co-development
- Consulting
- Licensing